RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 American College of Cardiology/European Society of Cardiology Joint Symposium on Lipids
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 2
SP 29
OP 30
DO 10.1177/155989770800800224
UL http://mdc.sagepub.com/content/8/2/29.abstract
AB When the results of the Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation [ILLUSTRATE] trial [Nissen SJ et al. N Engl J Med 2007] called into question the efficacy of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, many thought it signaled the end of the pursuit of these compounds for the treatment of dyslipidemia. This article discusses new data from ILLUSTRATE, which provide hope for the future of CETP inhibitors.